Compare AdaptHealth Corp (AHCO) vs JPMorgan Chase & Co (JPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AdaptHealth Corp vs JPMorgan Chase & Co — how do they compare? AdaptHealth Corp trades at $5.8 (market cap $753.09M), while JPMorgan Chase & Co trades at $365.44 (market cap $962.37B). The key difference: JPMorgan Chase & Co is far larger — about 1277.9× AdaptHealth Corp's market cap, and JPMorgan Chase & Co pays a 1.66% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | JPM | |
|---|---|---|
Market Cap | $753.09M | $962.37B |
Sector | Health | Financials |
52-Week High | $13.38 | $362.04 |
52-Week Low | $5.22 | $282.84 |
Enterprise Value | $2.77B | — |
Volume | — | 10,479,943 |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $5.77, up 10.54% today but remains under significant pressure following recent earnings disappointments. The stock shows bearish technical signals with oversold RSI readings, while fundamentals reveal revenue growth but negative profitability margins. Recent news highlights multiple securities fraud investigations and a strategic shift through the sale of its diabetes unit to focus on sleep and respiratory care.
Despite 75% analyst buy ratings and an $11 consensus price target suggesting substantial upside, immediate risks are elevated. The company faces execution challenges with fixed-price contracts, ongoing legal scrutiny, and consecutive earnings misses. Investors must weigh the potential recovery against substantial operational and legal headwinds.
JPMorgan Chase & Co. (JPM) trades at $362.04, up 0.63% daily, with a bullish technical outlook and strong earnings beats in recent quarters. The stock shows robust fundamentals, including a P/E of 15.51 and ROE of 18.43%, supported by revenue growth to $181.85B in 2025. Recent news highlights CEO Jamie Dimon's economic warnings and positive analyst sentiment ahead of Q1 2026 earnings.
Outlook is positive with a consensus price target of $374.18, offering ~3.4% upside, but risks include geopolitical tensions, cybersecurity threats, and volatile cash flows. Investors should weigh strong profitability against macroeconomic headwinds for balanced exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →
